Kerry goralski
Professor
College of Pharmacy
Dalhousie University
Canada
Biography
Dr. KERRYÂ GORALSKI is affiliated to College of Pharmacy, Dalhousie University. Dr. KERRYÂ GORALSKI is currently providing services as Professor. Dr. KERRYÂ GORALSKI has authored I145and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. KERRYÂ GORALSKI contributions have acclaimed recognition from honourable subject experts around the world. Dr. KERRYÂ GORALSKI is actively associated with different societies and academies. Dr. KERRYÂ GORALSKI academic career is decorated with several reputed awards and funding. Dr. KERRYÂ GORALSKI research interests include Professor Goralski is currently researching the pharmacology of a group of natural product molecules called jadomycins with the goal of determining their usefulness in treating drug-resistant metastatic breast cancer. His second area of research is clinical pharmacokinetics that aims to understand the factors that lead to variability in drug responses and optimize drug therapies in specific clinical populations. His third research area focuses on the functional characterization of the fat tissue hormone chemerin to provide a better understanding of its involvement in obesity and obesity-associated diseases including cancer and cardiovascular diseases..
Research Interest
Professor Goralski is currently researching the pharmacology of a group of natural product molecules called jadomycins with the goal of determining their usefulness in treating drug-resistant metastatic breast cancer. His second area of research is clinical pharmacokinetics that aims to understand the factors that lead to variability in drug responses and optimize drug therapies in specific clinical populations. His third research area focuses on the functional characterization of the fat tissue hormone chemerin to provide a better understanding of its involvement in obesity and obesity-associated diseases including cancer and cardiovascular diseases.
Publications
-
Parlee SD, Wang Y, Poirier P, LaPointe M, Martin J, Bastien M, Cianflone C, Goralski, KB. Biliopancreatic diversion with duodenal switch modifies plasma chemerin in the early and long-term post-operative periods. Obesity. 2015: 23,1201-1208. epub 2015 May 9
-
Hall SR, Blundon HL, Ladda MA, Robertson AW, Martinez-Farina CF, Jakeman DL, Goralski KB. Jadomycin breast cancer cytotoxicity is mediated by a copper-dependent, reactive oxygen species-inducing mechanism. Pharmacology Research and Perspectives. 2015: 3(2). Published online Feb 2, 2015
-
Wilson JA*, Goralski KB*, Soroka SD, Morrison M, Mossop P, Sleno L, Wang Y, Anderson DR. An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysis. J. Clin. Pharmacol. 2014: 54, 901-909. Published online May 28, 2014. * Co-PIs and contributed equally to writing the manuscript.